The global respiratory syncytial virus respiratory syncytial virus treatment market is undergoing rapid growth, driven by rising vaccine uptake, impr ...

RSV is responsible for around 1 lakh deaths, over 3.6 million hospitalisations in children under age of 5 every year, ...

MPV tends to hit hardest in young children, older adults and people with weakened immune systems. A virologist explains.

As winter settles over Australia, it's not just the drop in temperature we notice—there's also a sharp rise in respiratory ...